BULL PHARMA: RISKS AND REALITIES

The rise of “rogue pharma” companies presents a serious risks to public health, but the picture is often more intricate than initial reports suggest. These organizations , frequently operating outside standard regulatory frameworks, may offer different therapies at lower costs, appealing to vulne